| Bioactivity | Bafetinib is a potent and orally active Lyn/Bcr-Abl tyrosine kinase inhibitor. Bafetinib augments the activities of several proapoptotic Bcl-2 homology (BH)3-only proteins (Bim, Bad, Bmf and Bik) and induces apoptosis in Ph+ leukemia cells via Bcl-2 family-regulated intrinsic apoptosis pathway[1]. | ||||||||||||
| Name | Bafetinib | ||||||||||||
| CAS | 859212-16-1 | ||||||||||||
| Formula | C30H31F3N8O | ||||||||||||
| Molar Mass | 576.62 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Bafetinib
CAS: 859212-16-1 F: C30H31F3N8O W: 576.62
Bafetinib is a potent and orally active Lyn/Bcr-Abl tyrosine kinase inhibitor. Bafetinibaugments the activities of sever
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.